The Genetically Modified Polysialylated Form of Neural Cell Adhesion Molecule-Positive Cells for Potential Treatment of X-Linked Adrenoleukodystrophy
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Cell transplantation of myelin-producing exogenous cells is being extensively explored as a means of remyelinating axons in X-linked adrenoleukodystrophy. We determined whether 3,3’,5-Triiodo-L-thyronine (T3) overexpresses the ABCD2 gene in the polysialylated (PSA) form of neural cell adhesion molecule (NCAM)-positive cells and promotes cell proliferation and favors oligodendrocyte lineage differentiation. Materials and Methods: PSA-NCAM+ cells from newborn Sprague-Dawley rats were grown for five days on uncoated dishes in defined medium with or without supplementation of basic fibroblast growth factor (bFGF) and/or T3. Then, PSA-NCAM+ spheres were prepared in single cells and transferred to polyornithine/fibronectin-coated glass coverslips for five days to determine the fate of the cells according to the supplementation of these molecules. T3 responsiveness of ABCD2 was analyzed using real-time quantitative polymerase chain reaction, the growth and fate of cells were determined using 5-bromo-2-deoxyuridine incorporation and immunocytochemistry, respectively. Results: Results demonstrated that T3 induces overexpression of the ABCD2 gene in PSA-NCAM+ cells, and can enhance PSA-NCAM+ cell growth in the presence of bFGF, favoring an oligodendrocyte fate. Conclusion: These results may provide new insights into investigation of PSA-NCAM+ cells for therapeutic application to X-linked adrenoleukodystrophy.
Abstract
Purpose: Cell transplantation of myelin-producing exogenous cells is being extensively explored as a means of remyelinating axons in X-linked adrenoleukodystrophy. We determined whether 3,3’,5-Triiodo-L-thyronine (T3) overexpresses the ABCD2 gene in the polysialylated (PSA) form of neural cell adhesion molecule (NCAM)-positive cells and promotes cell proliferation and favors oligodendrocyte lineage differentiation. Materials and Methods: PSA-NCAM+ cells from newborn Sprague-Dawley rats were grown for five days on uncoated dishes in defined medium with or without supplementation of basic fibroblast growth factor (bFGF) and/or T3. Then, PSA-NCAM+ spheres were prepared in single cells and transferred to polyornithine/fibronectin-coated glass coverslips for five days to determine the fate of the cells according to the supplementation of these molecules. T3 responsiveness of ABCD2 was analyzed using real-time quantitative polymerase chain reaction, the growth and fate of cells were determined using 5-bromo-2-deoxyuridine incorporation and immunocytochemistry, respectively. Results: Results demonstrated that T3 induces overexpression of the ABCD2 gene in PSA-NCAM+ cells, and can enhance PSA-NCAM+ cell growth in the presence of bFGF, favoring an oligodendrocyte fate. Conclusion: These results may provide new insights into investigation of PSA-NCAM+ cells for therapeutic application to X-linked adrenoleukodystrophy.
참고문헌 (14)
- Moser HW, "Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy", Brain, 120, pp.1485~1508 (1997)
- Cartier N, "Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy", Science, 326, pp.818~823 (2009)
- Duncan ID, "Oligodendrocytes and stem cell transplantation: their potential in the treatment of leukoencephalopathies", J Inherit Metab Dis, 28, pp.357~368 (2005)
- Decker L, "Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors, and substrates", Mol Cell Neurosci, 16, pp.422~439 (2000)
- Grinspan J, "Cells and signaling in oligodendrocyte development", J Neuropathol Exp Neurol, 61, pp.297~306 (2002)
- Ben-Hur T, "Growth and fate of PSA-NCAM+ precursors of the postnatal brain", J Neurosci, 18, pp.5777~5788 (1998)
- Kemp S, "X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment", Mol Genet Metab, 90, pp.268~276 (2007)
- Fourcade S, "Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2)", Mol Pharmacol, 63, pp.1296~1303 (2003)
- Lubetzki C, "Morphological, biochemical, and functional characterization of bulk isolated glial progenitor cells", J Neurochem, 56, pp.671~680 (1991)
- Griffin DE, "Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy", Ann Neurol, 18, pp.660~664 (1985)
- Moser HW, "Bone marrow transplant in adrenoleukodystrophy", Neurology, 34, pp.1410~1417 (1984)
- Aubourg P, "Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation", N Engl J Med, 322, pp.1860~1866 (1990)
- Korenke GC, "Glyceroltrioleate", glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy, Eur J Pediatr, pp.1995, 154[DOI]
- Baas D, "Expression of alpha and beta thyroid receptors during oligodendrocyte differentiation", Neuroreport, 5, pp.1805~1808 (1994)